Rapamycin perfluorocarbon nanoparticle mitigates cisplatin-induced acute kidney injury

Authors

Qingyu Zhou, University of South Florida
James D Quirk, Washington University School of Medicine in St. Louis
Ying Hu, Washington University School of Medicine in St. Louis
Huimin Yan, Washington University School of Medicine in St. Louis
Joseph P Gaut, Washington University School of Medicine in St. Louis
Christine T N Pham, Washington University School of Medicine in St. Louis
Samuel A Wickline, University of South Florida
Hua Pan, Washington University School of Medicine in St. Louis

Journal

International Journal of Molecular Sciences

Publication Date

3-23-2023

Volume

24

Issue

7

First Page

6086

Document Type

Open Access Publication

DOI

10.3390/ijms24076086

Rights and Permissions

Zhou, Q.; Quirk, J.D.; Hu, Y.; Yan, H.; Gaut, J.P.; Pham, C.T.N.; Wickline, S.A.; Pan, H. Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury. Int. J. Mol. Sci. 2023, 24, 6086. https://doi.org/10.3390/ijms24076086 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Zhou, Qingyu; Quirk, James D; Hu, Ying; Yan, Huimin; Gaut, Joseph P; Pham, Christine T N; Wickline, Samuel A; and Pan, Hua, "Rapamycin perfluorocarbon nanoparticle mitigates cisplatin-induced acute kidney injury." International Journal of Molecular Sciences. 24, 7. 6086 (2023).
https://digitalcommons.wustl.edu/oa_4/1946

Department

ICTS (Institute of Clinical and Translational Sciences)